Pressure is rising in Europe and will force the medical-technology (medtech) industry to fundamentally change how it operates.
CHALLENGES ON A NUMBER OF FRONTS
The outlook for medtech in Europe is deteriorating as pricing pressure mounts, competition intensifies, and payers demand clear evidence of the cost-benefit tradeoff for products.
COMPANIES MUST OPTIMIZE THE EXISTING BUSINESS
Medtech companies need to make the most of their current operations by taking steps to transform their commercial model, prove the clinical and economic value of products, and improve their cost structure.
CHANGING THE PLAYING FIELD
Medtech companies must also reinvent how and where they compete—an effort that includes innovating differently, expanding to adjacent markets, and exploring the “value” segment.
See BCG report here